Position in VRTX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$22,839,645
-$8,736,984 QoQ
Shares Held
45,980
-35.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#240
of 1,705 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $117,820,260 across 121 Biotechnology names. VRTX ranks #1 (19.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
45,980 | $22,839,645 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,063 | $11,263,003 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
30,242 | $9,103,749 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
40,460 | $7,577,348 | |
| 5 | INSM |
INSMED Inc
|
48,273 | $5,146,867 | |
| 6 | INCY |
Incyte Corp
|
29,027 | $3,290,500 | |
| 7 | RPRX |
Royalty Pharma plc
|
55,752 | $3,126,014 | |
| 8 | MRNA |
Moderna, Inc.
|
39,368 | $2,756,941 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,839,645 | 45,980 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $31,576,629 | 70,714 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $29,818,847 | 65,773 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $24,473,975 | 62,491 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $27,869,520 | 62,600 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $23,838,114 | 49,169 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $19,533,768 | 48,507 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $22,308,957 | 47,968 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $22,355,600 | 47,695 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $24,690,178 | 59,066 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $23,865,319 | 58,653 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $20,200,564 | 58,091 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $20,200,337 | 57,402 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $18,107,387 | 57,471 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $16,212,109 | 56,140 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $14,844,715 | 51,270 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $13,384,461 | 47,498 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $7,124,481 | 27,300 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $5,878,033 | 26,767 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $4,296,947 | 23,689 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $5,023,611 | 24,915 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $8,199,772 | 38,158 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $9,040,241 | 38,251 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $10,181,369 | 37,415 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $10,855,561 | 37,393 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||